- Page 1 and 2: FINAL PROGRAMME Congress Organizers
- Page 3 and 4: WELCOMING WORDS Dear Colleagues, It
- Page 5 and 6: FACULTY LIST Marcello Arca, Italy J
- Page 7: ACKNOWLEDGEMENTS CORPORATE PARTNERS
- Page 11 and 12: THE ANITSCHKOW PRIZE THE ANITSCHKOW
- Page 13 and 14: GENERAL INFORMATION VENUE LYON Cong
- Page 15 and 16: MANDATORY CONFLICT OF INTEREST DISC
- Page 17 and 18: OVERVIEW OF MODERATED POSTER SESSIO
- Page 19 and 20: Track 3: RISK FACTORS, EPIDEMIOLOGY
- Page 21 and 22: MONDAY, JUNE 3, 2013 13.00-14.30 -
- Page 23 and 24: Opening Ceremony SUNDAY JUNE 2, 201
- Page 25 and 26: HALL NAME EULOGY OF DISTINGUISHED S
- Page 27 and 28: MARCEL MéRIEUx (1870-1937) BIOCHEM
- Page 29 and 30: VENUE FLOOR PLANS XXIX
- Page 31 and 32: SPONSOR AND ExHIbITOR PROFILES Aege
- Page 33 and 34: DENKA SEIKEN CO.,LTD. Nihonbashi Mi
- Page 35 and 36: Kowa 105 Wharfedale Road Winnersh T
- Page 37 and 38: Roche Grenzacherstrasse 124 4070 Sw
- Page 39 and 40: SCIENTIFIC PROGRAMME SUNDAY, JUNE 2
- Page 41 and 42: Sunday, June 2, 2013 11:00-20:30 Re
- Page 43 and 44: Sunday, June 2, 2013 16:20-17:50 Fo
- Page 45 and 46: SCIENTIFIC PROGRAMME MONDAY, JUNE 3
- Page 47 and 48: Monday, June 3, 2013 08:30-10:30 Au
- Page 49 and 50: Monday, June 3, 2013 10:50-12:40 Fo
- Page 51 and 52: Monday, June 3, 2013 12:50-13:40 Fo
- Page 53 and 54: Monday, June 3, 2013 14:50-16:40 Fo
- Page 55 and 56: Monday, June 3, 2013 17:00-18:30 Au
- Page 57: SCIENTIFIC PROGRAMME TUESDAY, JUNE
- Page 60 and 61:
Tuesday, June 4, 2013 10:50-12:40 F
- Page 62 and 63:
Tuesday, June 4, 2013 10:50-12:40 F
- Page 64 and 65:
Tuesday, June 4, 2013 14:50-16:40 F
- Page 66 and 67:
Tuesday, June 4, 2013 14:50-16:40 F
- Page 69:
SCIENTIFIC PROGRAMME WEDNESDAY, JUN
- Page 72 and 73:
Wednesday, June 5, 2013 10:50-12:40
- Page 74 and 75:
Wednesday, June 5, 2013 10:50-12:40
- Page 76 and 77:
Written by top experts in the field
- Page 78 and 79:
Monday, June 3, 2013 13:40-14:40 Mo
- Page 80 and 81:
Monday, June 3, 2013 13:40-14:40 Mo
- Page 82 and 83:
Monday, June 3, 2013 13:40-14:40 Mo
- Page 84 and 85:
Monday, June 3, 2013 13:40-14:40 Mo
- Page 86 and 87:
Tuesday, June 4, 2013 12:40-13:40 M
- Page 88 and 89:
Tuesday, June 4, 2013 12:40-13:40 M
- Page 90 and 91:
Tuesday, June 4, 2013 12:40-13:40 M
- Page 92 and 93:
Tuesday, June 4, 2013 12:40-13:40 M
- Page 94 and 95:
Tuesday, June 4, 2013 12:40-13:40 M
- Page 96 and 97:
Tuesday, June 4, 2013 13:40-14:40 M
- Page 98 and 99:
Tuesday, June 4, 2013 13:40-14:40 M
- Page 100 and 101:
Tuesday, June 4, 2013 13:40-14:40 M
- Page 102 and 103:
Tuesday, June 4, 2013 13:40-14:40 M
- Page 104 and 105:
Monday, June 3 - Wednesday, June 5,
- Page 106 and 107:
POSTERS TRACK 1 VASCULAR BIOLOGY OF
- Page 108 and 109:
POSTERS TRACK 1 VASCULAR BIOLOGY OF
- Page 110 and 111:
POSTERS TRACK 1 VASCULAR BIOLOGY OF
- Page 112 and 113:
POSTERS TRACK 1 VASCULAR BIOLOGY OF
- Page 114 and 115:
POSTERS TRACK 1 VASCULAR BIOLOGY OF
- Page 116 and 117:
POSTERS TRACK 1 VASCULAR BIOLOGY OF
- Page 118 and 119:
POSTERS TRACK 2 LIPID AND LIPOPROTE
- Page 120 and 121:
POSTERS TRACK 2: LIPID AND LIPOPROT
- Page 122 and 123:
POSTERS TRACK 2: LIPID AND LIPOPROT
- Page 124 and 125:
POSTERS TRACK 2: LIPID AND LIPOPROT
- Page 126 and 127:
POSTERS TRACK 2: LIPID AND LIPOPROT
- Page 128 and 129:
POSTERS TRACK 2: LIPID AND LIPOPROT
- Page 130 and 131:
POSTERS TRACK 2: LIPID AND LIPOPROT
- Page 132 and 133:
POSTERS TRACK 2: LIPID AND LIPOPROT
- Page 134 and 135:
POSTERS TRACK 2: LIPID AND LIPOPROT
- Page 136 and 137:
POSTERS TRACK 2: LIPID AND LIPOPROT
- Page 138 and 139:
POSTERS TRACK 2: LIPID AND LIPOPROT
- Page 140 and 141:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 142 and 143:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 144 and 145:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 146 and 147:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 148 and 149:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 150 and 151:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 152 and 153:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 154 and 155:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 156 and 157:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 158 and 159:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 160 and 161:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 162 and 163:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 164 and 165:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 166 and 167:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 168 and 169:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 170 and 171:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 172 and 173:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 174 and 175:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 176 and 177:
POSTERS TRACK 3: RISK FACTORS, EPID
- Page 178 and 179:
L Arteriosclerosis, Thrombosis, and
- Page 180 and 181:
Al-Jenabi, A. .....................
- Page 182 and 183:
Barter, P. ........................
- Page 184 and 185:
Bouillet, B. ......................
- Page 186 and 187:
Changarotti, J. ...................
- Page 188 and 189:
Cuniberti, L. .....................
- Page 190 and 191:
Dubois, N. ........................
- Page 192 and 193:
Fjornes, T. .......................
- Page 194 and 195:
Gogou, M. .........................
- Page 196 and 197:
Heeren, J. ........................
- Page 198 and 199:
Ito, Y. ...........................
- Page 200 and 201:
Kaudewitz, D. .....................
- Page 202 and 203:
Krajcoviechova, A. ................
- Page 204 and 205:
Lewis, G. .........................
- Page 206 and 207:
Mallol, R. ........................
- Page 208 and 209:
Mikołajczyk, T. ..................
- Page 210 and 211:
Nash, G. ..........................
- Page 212 and 213:
Østerud, B. ......................
- Page 214 and 215:
Picard, P. ........................
- Page 216 and 217:
Ribalta, J. .......................
- Page 218 and 219:
Saponaro, C. ......................
- Page 220 and 221:
Skrbic, R. ........................
- Page 222 and 223:
Tang, Z.H. ........................
- Page 224 and 225:
V Vacula, I. ......................
- Page 226 and 227:
Wang, K.-Y. .......................
- Page 228:
Zeiher, A. ........................